Project/Area Number |
24590066
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Physical pharmacy
|
Research Institution | Setsunan University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
KONISHI Motomi 摂南大学, 薬学部, 准教授 (20229446)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Keywords | プリオンタンパク質 / フラグメントペプチド / 酵素耐性 / 凝集性 / MT-MMP / カラムスイッチHPLC / MT1-MMP / マトリックスメタロプロテアーゼ / プロテアーゼ耐性 / Cu2+ |
Outline of Final Research Achievements |
At first, we investigated the metal-binding ability of 21 synthetic peptides by column switch HPLC system composed of a metal chelate affinity column and an ODS reversed-phase column. Second, the conformational change by copper ion was analyzed by comparison of CD spectra. Third, each peptide was individually incubated with recombinant MT1-MMP, MT3-MMP, MMP-7 or human serum in the presence or absence of copper ion and the cleavage sites determined by LC-ESI-MS. The data obtained from this study suggest that MT-MMPs expressed in the brain might possess the degrading activity of prion protein. Finally, we analyzed the intermolecular interaction of hPrP fragment peptide by using a column switch HPLC system and AFFINIX QN system. The results obtained this experiment suggest that hPrP150-159 may play an important role for aggregation of hPrP. We are now continuously investigating the key amino acid sequence for aggregation of hPrP and NMR analysis.
|